Cargando…

Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway

The aim of the present study was to evaluate the effects of the B7/cluster of differentiation (CD)28 signaling pathway on experimental lupus nephritis and examine the molecular mechanism involved by inhibiting the B7/CD28 signaling pathway. A lupus nephritis model in C57BL/6 J mice was induced via i...

Descripción completa

Detalles Bibliográficos
Autores principales:	HUANG, LI, KONG, YONG, WANG, JING, SUN, JIE, SHI, QIN, QIU, YU-HUA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526067/ https://www.ncbi.nlm.nih.gov/pubmed/26096149 http://dx.doi.org/10.3892/mmr.2015.3953

Ejemplares similares

CD3(+)CD8(+)CD28(−) T Lymphocytes in Patients with Lupus Nephritis
por: Żabińska, Marcelina, et al.
Publicado: (2016)

CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013)

DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
por: Liu, Xingzhong, et al.
Publicado: (2023)

Correction: CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013)

Accelerated Glomerular Cell Senescence in Experimental Lupus Nephritis
por: Yang, Chen, et al.
Publicado: (2018)

Excessive IL-15 promotes cytotoxic CD4 + CD28− T cell-mediated renal injury in lupus nephritis
por: Zhang, Ti, et al.
Publicado: (2022)

Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022)

JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016)

An Uncommon Correlation of Rheumatoid Arthritis and Lupus Nephritis: A Case Report on the Unusual Progression of Lupus Nephritis
por: Lam, Lyna C, et al.
Publicado: (2022)

Reduced Renal CSE/CBS/H2S Contributes to the Progress of Lupus Nephritis
por: Wang, Xuan, et al.
Publicado: (2023)

Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016)

The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
por: Yung, Susan, et al.
Publicado: (2012)

Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2008)

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
por: Chalmers, Samantha A., et al.
Publicado: (2022)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

Correction: Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2009)

CD11b Activity Modulates Pathogenesis of Lupus Nephritis
por: Khan, Samia Q., et al.
Publicado: (2018)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis
por: Wang, Da-Cheng, et al.
Publicado: (2023)

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients
por: Daamen, Andrea R., et al.
Publicado: (2023)

Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway
por: Hu, Qiongyi, et al.
Publicado: (2015)

CD4(+)CD25(-)Foxp3(+) T cells: a marker for lupus nephritis?
por: Bonelli, Michael, et al.
Publicado: (2014)

CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis
por: Lv, Fu, et al.
Publicado: (2022)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice
por: Uchida, Takahiro, et al.
Publicado: (2018)

Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2
por: Seo, Yohan, et al.
Publicado: (2020)

Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis
por: Qiu, Shiyuan, et al.
Publicado: (2021)

The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
por: Mejía-Vilet, Juan M., et al.
Publicado: (2021)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3phf5cevdsflr3qbq40n05qina